AKT1 and gastric cancer: The encouraging therapeutic enhancement achieved through the nano‐delivery system underlines the potential of this dual‐drug co‐delivery approach as a promising therapeutic avenue for advancing GC treatment by combining chemotherapy and AKT inhibition.